Related Experiment Videos
Lymphocyte responses following open and minimally invasive thoracic surgery
H A Leaver1, S R Craig, P L Yap
1Royal Infirmary of Edinburgh; University of Edinburgh, Edinburgh, UK.
European Journal of Clinical Investigation
|February 26, 2000
Summary
Minimally invasive thoracic surgery, or VATS, causes less immune suppression than conventional surgery. This leads to quicker recovery of key immune cells after pulmonary lobectomy for lung cancer.
Area of Science:
- Immunology
- Thoracic Surgery
- Oncology
Background:
- Surgical immunosuppression can increase cancer recurrence risk.
- Lymphocytes are crucial for anti-tumor immune responses.
- Comparing surgical approaches is vital for immune function preservation.
Purpose of the Study:
- To compare the impact of minimally invasive (VATS) versus conventional thoracic surgery on lymphocyte populations and oxidative activity.
- To evaluate immune recovery post-pulmonary lobectomy.
Main Methods:
- Prospective randomized study of 41 patients undergoing lobectomy.
- Analysis of T cells (CD4, CD8), B cells (CD19), and NK cells (CD56, CD16) pre- and post-surgery.
- Measurement of lymphocyte oxidative activity compared to healthy controls.
Main Results:
- Both surgical methods decreased lymphocyte counts post-operation.
- VATS showed a less pronounced reduction in T (CD4) and NK cells at 2 and 7 days, respectively.
- Lymphocyte oxidative activity was less suppressed after VATS, with faster recovery of immune cells.
Conclusions:
- The invasiveness of thoracic surgery impacts the degree of immunosuppression.
- VATS may offer immunological advantages over conventional surgery for pulmonary lobectomy.
- Minimizing surgical invasiveness can better preserve cellular immunity in lung cancer patients.